References
- Atlas of MS 2013. London: Multiple Sclerosis International Federation, 2013.
- Browne P, Chandraratna D, Angood C, et al. Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014;83(11):1022–1024.
- Galushko M, Golla H, Strupp J, et al. Unmet needs of patients feeling severely affected by multiple sclerosis in Germany: a qualitative study. J Palliat Med. 2014;17(3):274–281.
- Strupp J, Hartwig A, Golla H, et al. Feeling severely affected by multiple sclerosis: what does this mean? Palliat Med. 2012;26(8):1001–1010.
- Pohar SL, Jones CA, Warren S, et al. Health status and health care utilization of multiple sclerosis in Canada. Can J Neurol Sci. 2007;34(2):167–174.
- Kersten P, McLellan DL, Gross-Paju K, et al. A questionnaire assessment of unmet needs for rehabilitation services and resources for people with multiple sclerosis: results of a pilot survey in five European countries. Needs task group of MARCH (multiple sclerosis and rehabilitation, care and health services research in Europe). Clin Rehabil. 2000; 14:42–49.
- Koopman WJ, Benbow CL, Vandervoort M. Top 10 needs of people with multiple sclerosis and their significant others. J Neurosci Nurs. 2006;38(5):369–373.
- Edmonds P, Vivat B, Burman R, et al. Fighting for everything’: service experiences of people severely affected by multiple sclerosis. Mult Scler. 2007;13(5):660–667.
- Somerset M, Sharp D, Campbell R. Multiple sclerosis and quality of life: a qualitative investigation. J Health Serv Res Policy. 2002;7:151–159.
- Rivera VM. Multiple sclerosis: a global concern with multiple challenges in an era of advanced therapeutic complex molecules and biological medicines. Biomedicines. 2018;6(4):112.
- Cheong WL, Mohan D, Warren N, et al. Multiple sclerosis in the asia pacific region: a systematic review of a neglected neurological disease. Front Neurol. 2018; 9:432.
- Atlas Country Resources for Neurological Disorders. Geneva: World Health Organization; 2004.
- Mohammadi D. Neurology in resource-poor countries: fighting for funding. Lancet Neurol. 2011;10(11):953–954.
- Viswanathan S, Wah LM. A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia. Mult Scler. 2019;25(11):1452–1461.
- Braun V, Clarke V. Successful qualitative research: a practical guide for beginners. London: Sage Publications; 2013.
- Rieckmann P, Centonze D, Elovaara I, et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: a combined perspective from the MS in the 21st century steering group. Mult Scler Relat Disord. 2018;19:153–160.
- Rehabilitation: recommendations for persons with multiple sclerosis. New York (NY): National Multiple Sclerosis Society; 2006.
- Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Adv Therapy. 2009;26(12):1043–1057.
- Freeman JA, Thompson AJ. Community services in multiple sclerosis: still a matter of chance. J Neurol Neurosurg Psychiatry. 2000;69:728.
- Recommendations for Care of Those Affected by Multiple Sclerosis. Seattle (WA): Consortium of Multiple Sclerosis Centers; 2005.
- Playford ED. Work status in MS: a proxy measure for comprehensive MS management. Mult Scler. 2016;22(14):1766–1767.
- Rehabilitation and disability in the Western Pacific. Manila: World Health Organization Regional Office for the Western Pacific; 2017.
- Milanese C. Unmet needs in multiple sclerosis: the role of community services. J Neurol Neurosurg Psychiatry. 2000;69:715.
- Vijayasingham L, Jogulu U, Allotey P. Challenges for accessing and financing high-cost medicines in multipayer systems: case studies of multiple sclerosis in Malaysia. Critical Public Health. 2019;29(1):74–83.
- Whetten-Goldstein K, Sloan FA, Goldstein LB, et al. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler. 1998;4(5):419–425.
- Naci H, Fleurence R, Birt J, et al. Economic burden of multiple sclerosis. Pharmacoeconomics. 2010;28(5):363–379.
- Abdullah JM, Hussin AM, Tharakan J, et al. National response to neurological diseases in Malaysia: planning for the future. Southeast Asian J Trop Med Public Health. 2006;37(4):798–805.
- Kanavos P, Mossman J. Changing paradigms in the management of Multiple Sclerosis. LSE Politi Sci. 2018;24(9):1251–1255.
- Wilsdon T, Barron A, Mitchell-Heggs A, et al. Access to medicines for multiple sclerosis: challenges and opportunities. Boston (MA): Charles River Associates; 2014.
- Mitchell AJ, Benito-Leon J, Gonzalez JM, et al. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol. 2005;4(9):556–566.
- Sadovnick AD, Eisen K, Ebers GC, et al. Cause of death in patients attending multiple sclerosis clinics. Neurology. 1991;41(8):1193.
- Bridging Barriers: A Report on Improving Access to Mental Healthcare in Malaysia. Kuala Lumpur: Penang Institute; 2018.
- Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357(10):1018–1027.
- Hotez P. Measuring neglect. PLoS Negl Trop Dis. 2007;1(2):e118.
- Vijayasingham L, Mairami FF. Employment of patients with multiple sclerosis: the influence of psychosocial-structural coping and context. DNND. 2018;8:15–24.
- Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
- Golla H, Galushko M, Pfaff H, et al. Multiple sclerosis and palliative care – perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study. BMC Palliat Care. 2014;13(1):11.